Celistar Microneedling Infusion Liquid
NDC Package 87765-001-01
Package Information
Celistar Microneedling Infusion (hyaluronate sodium) liquids is a medication used to protect skin ulcers, burns, or wounds from irritation so that the skin can heal properly. This formulation utilizes a liquid delivery system. Marketed by Guangdong Outeli Biotechnology Co., Ltd., this product is identified by NDC 87765-001 and is authorized under FDA application M016.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87765 - Guangdong Outeli Biotechnology Co., Ltd.
- 87765-001 - Celistar Microneedling Infusion
- 87765-001-01 - 20 mL in 1 BOX
- 87765-001 - Celistar Microneedling Infusion
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (87765-001). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87765-001-01 identifies a specific commercial package of 20 ml in 1 box of Celistar Microneedling Infusion, a human over the counter drug labeled by Guangdong Outeli Biotechnology Co., Ltd.. This liquid is formulated for topical use and contains hyaluronate sodium; hydrolysed marine collagen (enzymatic; 2000 mw) as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Outeli Biotechnology Co., Ltd. on June 10, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to protect skin ulcers, burns, or wounds from irritation so that the skin can heal properly. Some products are also used to help relieve itching and pain from various skin conditions. Hyaluronate is the same as a natural substance that is found in your body. It works by forming a protective layer over the affected area.
How is this Guangdong Outeli Biotechnology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87765000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.